About Pfizer, Inc. - CK 1 Business
Available information shows that Pfizer, Inc. - CK 1 Business is private tracked on Acquity Data. Pfizer, Inc. - CK 1 Business appears in Acquity Data's private market intelligence platform.
2
Transactions
Sign up to view
$75M
Deal Value
Sign up to view
Investors
Current Investors
Biogen, Inc.
••••••••
Past Investors
••••••••
••••••••
Investment Details
2 Transactions
| Trans. ID | Investment Date | Exit Date | Investor(s) | Deal Size (M) | Seller(s) |
|---|---|---|---|---|---|
Pfizer, Inc. - CK 1 Business M&A Activity
| # | Company | Transaction Date | Close Date | Sector | Country |
|---|---|---|---|---|---|
|
|
|||||
|
|
|||||
|
|
|||||
|
|
Key Executives & Professionals
Frequently Asked Questions
What does Pfizer, Inc. - CK 1 Business do?
Available information shows that Pfizer, Inc. - CK 1 Business is private tracked on Acquity Data. Pfizer, Inc. - CK 1 Business appears in Acquity Data's private market intelligence platform.
Where is Pfizer, Inc. - CK 1 Business headquartered?
Location information for Pfizer, Inc. - CK 1 Business is available on AcquityData.
When was Pfizer, Inc. - CK 1 Business founded?
Founded year information for Pfizer, Inc. - CK 1 Business is available on AcquityData.
What sector is Pfizer, Inc. - CK 1 Business in?
Sector information for Pfizer, Inc. - CK 1 Business is available on AcquityData.
Who are the investors in Pfizer, Inc. - CK 1 Business?
Current investors in Pfizer, Inc. - CK 1 Business include Biogen, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Pfizer, Inc. - CK 1 Business been involved in?
Pfizer, Inc. - CK 1 Business has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.
Unlock the full Pfizer, Inc. - CK 1 Business profile
Ownership & Investors
M&A History
Financials
Key Executives
Advisors & Lenders
Access Pfizer, Inc. - CK 1 Business's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.
Start Free Trial